Clinical Trials

Search for trials
Clinical Trial
  • Status: Recruiting
  • Phase: Phase 2
  • Intervention Type: Drug, Biological
  • Participants: 40
  • Start Date: November 30, 2020
A Pilot Study of Dinutuximab, Sargramostim (GM-CSF), and Isotretinoin in Combination With Irinotecan and Temozolomide in the Post-Consolidation Setting for High-Risk Neuroblastoma
Clinical Trial
  • Status: Recruiting
  • Phase: Early Phase 1
  • Intervention Type: Drug, Procedure
  • Participants: 20
  • Start Date: September 23, 2019
Utility of Gallium-68-DOTA-Octreotate PET/CT in the Characterization of Pediatric Neuroendocrine Tumors
Search for trials
Clinical Trial
  • Status: Recruiting
  • Phase: Phase 2
  • Intervention Type: Drug, Biological
  • Participants: 95
  • Start Date: May 28, 2019
A Phase 2 Randomized Study of Irinotecan/Temozolomide/Dinutuximab With or Without Eflornithine (DFMO) in Children With Relapsed, Refractory or Progressive Neuroblastoma
Clinical Trial
  • Status: Active, not recruiting
  • Phase: Phase 3
  • Intervention Type: Drug, Biological, Procedure, Radiation
  • Participants: 813
  • Start Date: May 9, 2018
A Phase 3 Study of 131I-Metaiodobenzylguanidine (131I-MIBG) or Crizotinib Added to Intensive Therapy for Children With Newly Diagnosed High-Risk Neuroblastoma (NBL)
Clinical Trial
  • Status: Recruiting
  • Phase: Phase 1
  • Intervention Type: Drug, Biological
  • Participants: 108
  • Start Date: March 5, 2018
Molecularly-Driven Doublet Therapy for All Children With Refractory or Recurrent CNS Malignant Neoplasms and Young Adults With Refractory or Recurrent SHH Medulloblastoma
Clinical Trial
  • Status: Recruiting
  • Phase: Phase 1
  • Intervention Type: Biological
  • Participants: 40
  • Start Date: November 25, 2014
A Phase 1 Feasibility and Safety Study of Cellular Immunotherapy for Recurrent/Refractory Neuroblastoma Using Autologous T-cells Lentivirally Transduced to Express CD171-specific Chimeric Antigen Receptors
Clinical Trial
  • Status: Recruiting
  • Phase: Phase 3
  • Intervention Type: Drug, Other
  • Participants: 621
  • Start Date: July 28, 2014
Utilizing Response- and Biology-Based Risk Factors to Guide Therapy in Patients With Non-High-Risk Neuroblastoma
Clinical Trial
  • Status: Recruiting
  • Phase: N/A
  • Intervention Type: Radiation
  • Participants: 30
  • Start Date: June 2014
Phase II Study of Proton Radiation Therapy for Neuroblastoma
Clinical Trial
  • Status: Recruiting
  • Participants: 600
  • Start Date: June 24, 2013
International Congenital Central Hypoventilation Syndrome (CCHS) REDCap Registry
Clinical Trial
  • Status: Recruiting
  • Phase: Phase 3
  • Intervention Type: Drug
  • Participants: 685
  • Start Date: December 2011
European Low and Intermediate Risk Neuroblastoma Protocol
Clinical Trial
  • Status: Recruiting
  • Intervention Type: Other
  • Participants: 10000
  • Start Date: November 6, 2000
Neuroblastoma Biology Studies
Showing 1-11 of 11